ESR1 and neoplasm: Accordingly, when we used a novel approach of using anti-E2 antibodies to capture proteins that were complexed with this hormone in blood and tumour-derived Treg cells, we observed that intracellular E2 was at least partially complexed with ERα, and might therefore be capable of modulating Treg cells function via this pathway.